Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients

Objective: The potential contribution of asymmetric dimethylarginine (ADMA) and high-sensitivity C reactive protein (hsCRP) to endothelial dysfunction in APS patients has not been studied in detail, until now. The study involved 105 APS patients (59 diagnosed with primary APS (PAPS) and 46 APS assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanisavljevic, Natasa, Stojanovich, Ljudmila, Djokovic, Aleksandra, Todic, Brankica, Dopsaj, Violeta, Saponjski, Jovica, Saponjski, Dusan, Markovic, Olivera, Belizna, Cristina, Zdravkovic, Marija, Marisavljevic, Dragomir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603922/
https://www.ncbi.nlm.nih.gov/pubmed/36293156
http://dx.doi.org/10.3390/ijms232012309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603922/
https://www.ncbi.nlm.nih.gov/pubmed/36293156
http://dx.doi.org/10.3390/ijms232012309

Ejemplares similares